US$ 22.96
glp-1 black box warning Carnivore_BTC @ethanjweiss @US_FDA @LillyPad One ongoing mystery in the GLP- 1 space is @US_FDA perpetuation of the for MTC, in the absence of any scientific evidence that this is warranted Metabolic dysfunction-associated steatotic liver disease
Description
[DOI] [PubMed] [Google Scholar] 752.Kastin A.J., Akerstrom V., Pan W

2024, www.help.senate.gov/hearings/why-is-novo-nordisk-charging-americans-with-diabetes-a nd-obesity-outrageously-high-prices-for-ozempic-and-wegovy.

J Neurosurg Anesthesiol 36(4): 278282

and lactase that's obtained from purified yeasts or fungi

These medications are FDA-approved for chronic weight management in adults with a BMI of 30 or greater (obesity) or a BMI of 27 or greater (overweight) with at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol
